1. International Diabetes Federation. Diabetes Atlas - 7th Edition. Brussels, Belgium: International Diabetes Federation; 2015.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14.
3. Ramachandran A, Snehalatha C, Mary S, Selvam S, Kumar CK, Seeli AC, Shetty AS. Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian diabetes prevention Programme-2 (IDPP-2). Diabetologia. 2009:1019–26.
4. Thankappan KR, Shah B, Mathur P, Sarma PS, Srinivas G, Mini GK, Soman MDB, Vasan RS. Risk factor profile for chronic non-communicable diseases: results of a community-based study in Kerala, India. Indian J Med Res. 2010;131:53–63.
5. Shah B, Mathur P. Surveillance of cardiovascular disease risk factors in India: the need & scope. Indian J Med Res. 2010;132:634–42.